Apontis Pharma AG

XETRA:APPH.DE

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

Germany

Market Cap

USD 105.37 M

Share Price

USD 12.65

Avg Daily Volume

809

Change (1 day)

0.89%

Change (1 year)

38.25%

Change (YTD)

20.95%

Apontis Pharma AG Total Assets for the year ending December 31, 2024

Apontis Pharma AG Total Assets is NA for the year ending December 31, 2024. Total assets are the total value of all assets owned by a company, representing its resources.

Apontis Pharma AG Total Assets for the year ending December 31, 2023 was USD 63.42 M, a -0.97% change year over year.
Apontis Pharma AG Total Assets for the year ending December 31, 2022 was USD 64.04 M, a 3.92% change year over year.
Apontis Pharma AG Total Assets for the year ending December 31, 2021 was USD 61.62 M, a 69.90% change year over year.
Apontis Pharma AG Total Assets for the year ending December 31, 2020 was USD 36.27 M, a 5.67% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Total Assets	Accounts Payable	Short-Term Debt	Long-Term Debt

XETRA: APPH.DE

Apontis Pharma AG

CEO	Mr. Bruno Eugen Wohlschlegel
IPO Date	May 11, 2021
Location	Germany
Headquarters	Alfred-Nobel-Str. 10
Employees	137
Sector	🏥 Health Care
Industries Pharmaceuticals 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies

Description

Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.

Similar companies

Eli Lilly and Company

USD 792.30

1.83%

AbbVie Inc.

USD 185.39

-0.09%

Roche Holding AG

USD 341.12

-1.04%

AstraZeneca PLC

USD 140.14

-0.36%

Merck & Co., Inc.

USD 79.67

-0.81%

Amgen Inc.

USD 280.35

1.03%

Pfizer Inc.

USD 24.26

-0.21%

Gilead Sciences, Inc.

USD 105.93

-1.19%

Sanofi

USD 95.90

-1.25%

Bristol-Myers Squibb Company

USD 46.68

-0.74%

Chugai Pharmaceutical Co., Ltd.

USD 52.21

0.11%

GSK plc

USD 19.07

-0.64%

Cencora, Inc.

USD 292.32

-0.61%

Regeneron Pharmaceuticals, Inc.

USD 520.29

-0.38%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.29

-1.15%

Haleon plc

USD 5.22

0.20%

Takeda Pharmaceutical Company Limited

USD 30.06

0.25%

Daiichi Sankyo Company, Limited

USD 22.75

-2.17%

UCB SA

USD 196.91

2.58%

Hansoh Pharmaceutical Group Company Limited

USD 3.66

-2.04%

Insmed Incorporated

USD 104.85

-0.99%

Teva Pharmaceutical Industries Limited

USD 17.07

-0.24%

West Pharmaceutical Services, Inc.

USD 221.02

-0.74%

Summit Therapeutics Inc.

USD 21.27

1.67%

Cipla Limited

USD 17.67

0.68%

United Therapeutics Corporation

USD 285.97

-1.37%

Dr. Reddy's Laboratories Limited

USD 15.43

-1.05%

Torrent Pharmaceuticals Limited

USD 37.11

-1.05%

Sino Biopharmaceutical Limited

USD 0.65

-2.09%

CSPC Pharmaceutical Group Limited

USD 0.99

-2.38%

Zydus Lifesciences Limited

USD 11.40

0.64%

Mankind Pharma Limited

USD 26.96

0.47%

Ascendis Pharma A/S

USD 173.00

-3.41%

Viatris Inc.

USD 8.89

-0.67%

BioMarin Pharmaceutical Inc.

USD 54.14

-1.01%

Orion Oyj

USD 73.45

0.35%

Lupin Limited

USD 22.53

0.16%

Swedish Orphan Biovitrum AB (publ)

USD 29.11

0.12%

Ipsen S.A.

USD 119.73

0.43%

Huadong Medicine Co., Ltd

USD 5.62

-0.40%

Kyowa Kirin Co., Ltd.

USD 17.15

0.68%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.07

-0.24%

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.51

-0.50%

Abbott India Limited

USD 370.22

0.53%

Eisai Co., Ltd.

USD 27.72

1.51%

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.89

0.65%

Shenzhen Salubris Pharmaceuticals Co., Ltd.

USD 6.45

-0.50%

Sinopharm Group Co. Ltd.

USD 2.37

0.01%

Beijing Tongrentang Co., Ltd

USD 5.12

0.41%

3SBio Inc.

USD 2.80

-1.78%

StockViz Staff

June 26, 2025

Any question? Send us an email